NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 216 filers reported holding NEKTAR THERAPEUTICS in Q4 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $34,000 | -24.4% | 10,650 | -10.1% | 0.02% | -16.7% |
Q2 2022 | $45,000 | -55.0% | 11,850 | -36.1% | 0.02% | -52.9% |
Q1 2022 | $100,000 | -98.4% | 18,550 | -95.9% | 0.05% | -98.4% |
Q4 2021 | $6,118,000 | -11.5% | 452,879 | +11.8% | 3.26% | -19.0% |
Q3 2021 | $6,913,000 | – | 404,972 | – | 4.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $82,950,000 | 2.19% |
MAVERICK CAPITAL LTD | 5,678,221 | $94,202,000 | 1.75% |
Rhenman & Partners Asset Management AB | 1,000,000 | $16,590,000 | 1.48% |
Goodman Financial Corp | 119,198 | $1,977,000 | 0.92% |
Bellevue Group AG | 3,632,358 | $60,261,000 | 0.83% |
OSTERWEIS CAPITAL MANAGEMENT INC | 477,004 | $7,914,000 | 0.53% |
Parametrica Management Ltd | 13,658 | $226,000 | 0.43% |
RICE HALL JAMES & ASSOCIATES, LLC | 592,930 | $9,837,000 | 0.40% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,110,000 | 0.36% |
Burleson & Company, LLC | 92,836 | $1,617,000 | 0.31% |